CD86 and systemic lupus erythematosus: Studies later revealed that within the B1 cell population of SLE patients, a predominantly CD11b+ population activates CD4+ T cells, which stimulate the activation and proliferation of CD4+ T cells by upregulating the CD86 molecule, mainly toward the Th17 cell population.